{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:46:05Z","timestamp":1790163965454,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016302","name":"Coalition for Epidemic Preparedness Innovations","doi-asserted-by":"crossref","award":["INTU1901"],"award-info":[{"award-number":["INTU1901"]}],"id":[{"id":"10.13039\/100016302","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Lassa virus (LASV) is the causative agent of Lassa fever, an often-fatal hemorrhagic disease that is endemic in West Africa. Seven genetically distinct LASV lineages have been identified. As part of CEPI\u2019s (Coalition for Epidemic Preparedness Innovations) Lassa vaccine development program, we assessed the potential of the human immune system to mount cross-reactive and cross-protective humoral immune responses to antigens from the most prevalent LASV lineages, which are lineages II and III in Nigeria and lineage IV in Sierra Leone. IgG and IgM present in the blood of Lassa fever survivors from Nigeria or Sierra Leone exhibited substantial cross-reactivity for binding to LASV nucleoprotein and two engineered (linked and prefusion) versions of the glycoproteins (GP) of lineages II\u2013IV. There was less cross-reactivity for the Zinc protein. Serum or plasma from Nigerian Lassa fever survivors neutralized LASV pseudoviruses expressing lineage II GP better than they neutralized lineage III or IV GP expressing pseudoviruses. Sierra Leonean survivors did not exhibit a lineage bias. Neutralization titres determined using LASV pseudovirus assays showed significant correlation with titres determined by plaque reduction with infectious LASV. These studies provide guidance for comparison of humoral immunity to LASV of distinct lineages following natural infection or immunization.<\/jats:p>","DOI":"10.1038\/s41598-020-72539-w","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T10:03:40Z","timestamp":1601373820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages"],"prefix":"10.1038","volume":"10","author":[{"given":"Megan L.","family":"Heinrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Boisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana K. S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane J.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoliy P.","family":"Koval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon J.","family":"Beddingfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Hastie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Rowland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Aimukanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Koval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju","family":"Lathigra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Borisevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mambu","family":"Momoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Demby","family":"Sandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Goba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"lkponmwosa","family":"Odia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Baimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John O.","family":"Aiyepada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benevolence","family":"Ebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philomena","family":"Eromon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinedu","family":"Ugwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onikepe","family":"Folarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Testimony","family":"Olumade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacDonald N.","family":"Onyechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnson","family":"Etafo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashidat","family":"Adeyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah E.","family":"Ella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Aminu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simji S.","family":"Gomerep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Afam","family":"Eke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olusola","family":"Ogunsanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George O.","family":"Akpede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny O.","family":"Asogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvanus A.","family":"Okogbenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter O.","family":"Okokhere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Schieffelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Ollmann","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian T.","family":"Happi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald S.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"72539_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fpubh.2019.00170","volume":"7","author":"GO Akpede","year":"2019","unstructured":"Akpede, G. O. et al. Caseload and case fatality of Lassa fever in Nigeria, 2001\u20132018: A specialist center\u2019s experience and its implications. Front. Public Health 7, 170. https:\/\/doi.org\/10.3389\/fpubh.2019.00170 (2019).","journal-title":"Front. Public Health"},{"key":"72539_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3201\/eid2506.181035","volume":"25","author":"EA Ilori","year":"2019","unstructured":"Ilori, E. A. et al. Epidemiologic and clinical features of Lassa fever outbreak in Nigeria, January 1\u2013May 6, 2018. Emerg. Infect. Dis. 25, 1066\u20131074. https:\/\/doi.org\/10.3201\/eid2506.181035 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"72539_CR3","doi-asserted-by":"publisher","first-page":"e2748","DOI":"10.1371\/journal.pntd.0002748","volume":"8","author":"JG Shaffer","year":"2014","unstructured":"Shaffer, J. G. et al. Lassa fever in post-conflict Sierra Leone. PLoS Negl. Trop. Dis. 8, e2748. https:\/\/doi.org\/10.1371\/journal.pntd.0002748 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"72539_CR4","first-page":"69","volume":"134","author":"JB McCormick","year":"1987","unstructured":"McCormick, J. B. Epidemiology and control of Lassa fever. Curr. Top Microbiol. Immunol. 134, 69\u201378 (1987).","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"72539_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0035-9203(77)90085-2","volume":"71","author":"RB Arnold","year":"1977","unstructured":"Arnold, R. B. & Gary, G. W. A neutralization test survey for Lassa fever activity in Lassa, Nigeria. Trans. R. Soc. Trop. Med. Hyg. 71, 152\u2013154 (1977).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"72539_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.185.4147.263","volume":"185","author":"TP Monath","year":"1974","unstructured":"Monath, T. P., Newhouse, V. F., Kemp, G. E., Setzer, H. W. & Cacciapuoti, A. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 185, 263\u2013265 (1974).","journal-title":"Science"},{"key":"72539_CR7","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3201\/eid1212.060812","volume":"12","author":"E Lecompte","year":"2006","unstructured":"Lecompte, E. et al. Mastomys natalensis and Lassa fever, West Africa. Emerg. Infect. Dis. 12, 1971\u20131974 (2006).","journal-title":"Emerg. Infect. Dis."},{"key":"72539_CR8","doi-asserted-by":"publisher","first-page":"25280","DOI":"10.1038\/srep25280","volume":"6","author":"A Olayemi","year":"2016","unstructured":"Olayemi, A. et al. New hosts of the Lassa virus. Sci. Rep. 6, 25280. https:\/\/doi.org\/10.1038\/srep25280 (2016).","journal-title":"Sci. Rep."},{"key":"72539_CR9","doi-asserted-by":"publisher","DOI":"10.3201\/eid2510.180523","author":"A Yadouleton","year":"2019","unstructured":"Yadouleton, A. et al. Lassa virus in pygmy mice, Benin, West Africa, 2016\u20132017. Emerg. Infect. Dis. https:\/\/doi.org\/10.3201\/eid2510.180523 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"72539_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/s1473-3099(18)30121-x","volume":"18","author":"P Okokhere","year":"2018","unstructured":"Okokhere, P. et al. Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: A retrospective, observational cohort study. Lancet. Infect. Dis 18, 684\u2013695. https:\/\/doi.org\/10.1016\/s1473-3099(18)30121-x (2018).","journal-title":"Lancet. Infect. Dis"},{"key":"72539_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101557","author":"A Duvignaud","year":"2020","unstructured":"Duvignaud, A. et al. Lassa fever clinical course and setting a standard of care for future randomized trials: A protocol for a cohort study of Lassa-infected patients in Nigeria (LASCOPE). Travel. Med. Infect. Dis. https:\/\/doi.org\/10.1016\/j.tmaid.2020.101557 (2020).","journal-title":"Travel. Med. Infect. Dis."},{"key":"72539_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.07.015","author":"KA Eberhardt","year":"2019","unstructured":"Eberhardt, K. A. et al. Ribavirin for the treatment of Lassa fever: A systematic review and meta-analysis. Int. J. Infect. Dis. https:\/\/doi.org\/10.1016\/j.ijid.2019.07.015 (2019).","journal-title":"Int. J. Infect. Dis."},{"key":"72539_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","volume":"159","author":"MS Mehand","year":"2018","unstructured":"Mehand, M. S., Al-Shorbaji, F., Millett, P. & Murgue, B. The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antiviral Res. 159, 63\u201367. https:\/\/doi.org\/10.1016\/j.antiviral.2018.09.009 (2018).","journal-title":"Antiviral Res."},{"key":"72539_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00103-019-03061-2","volume":"63","author":"V Bernasconi","year":"2020","unstructured":"Bernasconi, V. et al. Developing vaccines against epidemic-prone emerging infectious diseases. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 63, 65\u201373. https:\/\/doi.org\/10.1007\/s00103-019-03061-2 (2020).","journal-title":"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz"},{"key":"72539_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxz012","author":"D Gouglas","year":"2019","unstructured":"Gouglas, D., Christodoulou, M., Plotkin, S. A. & Hatchett, R. CEPI: Driving progress towards epidemic preparedness and response. Epidemiol. Rev. https:\/\/doi.org\/10.1093\/epirev\/mxz012 (2019).","journal-title":"Epidemiol. Rev."},{"key":"72539_CR16","unstructured":"Coalition for Epidemic Preparedness Innovations. Preparing for Lassa vaccine trials with targeted epidemiology studies. https:\/\/cepi.net\/get_involved\/cfps\/ (2019)."},{"key":"72539_CR17","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s00705-019-04253-6","volume":"164","author":"A Abudurexiti","year":"2019","unstructured":"Abudurexiti, A. et al. Taxonomy of the order Bunyavirales: Update 2019. Arch. Virol. 164, 1949\u20131965. https:\/\/doi.org\/10.1007\/s00705-019-04253-6 (2019).","journal-title":"Arch. Virol."},{"key":"72539_CR18","first-page":"5","volume":"263","author":"MB Oldstone","year":"2002","unstructured":"Oldstone, M. B. Arenaviruses. II. The molecular pathogenesis of arenavirus infections. Introduction. Curr. Top Microbiol. Immunol. 263, 5\u201312 (2002).","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"72539_CR19","first-page":"5","volume":"262","author":"MB Oldstone","year":"2002","unstructured":"Oldstone, M. B. Arenaviruses. I. The epidemiology molecular and cell biology of arenaviruses Introduction. Curr. Top Microbiol. Immunol. 262, 5\u201312 (2002).","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"72539_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00929-19","author":"DU Ehichioya","year":"2019","unstructured":"Ehichioya, D. U. et al. Phylogeography of Lassa virus in Nigeria. J. Virol. https:\/\/doi.org\/10.1128\/jvi.00929-19 (2019).","journal-title":"J. Virol."},{"key":"72539_CR21","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2015.07.020","volume":"162","author":"KG Andersen","year":"2015","unstructured":"Andersen, K. G. et al. Clinical sequencing uncovers origins and evolution of Lassa virus. Cell 162, 738\u2013750. https:\/\/doi.org\/10.1016\/j.cell.2015.07.020 (2015).","journal-title":"Cell"},{"key":"72539_CR22","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1128\/JVI.74.15.6992-7004.2000","volume":"74","author":"MD Bowen","year":"2000","unstructured":"Bowen, M. D. et al. Genetic diversity among Lassa virus strains. J.. Virol. 74, 6992\u20137004 (2000).","journal-title":"J.. Virol."},{"key":"72539_CR23","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1056\/NEJMoa1804498","volume":"379","author":"KJ Siddle","year":"2018","unstructured":"Siddle, K. J. et al. Genomic analysis of Lassa virus during an increase in cases in Nigeria in 2018. N. Engl. J. Med. 379, 1745\u20131753. https:\/\/doi.org\/10.1056\/NEJMoa1804498 (2018).","journal-title":"N. Engl. J. Med."},{"key":"72539_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aau9343","volume":"363","author":"LE Kafetzopoulou","year":"2019","unstructured":"Kafetzopoulou, L. E. et al. Metagenomic sequencing at the epicenter of the Nigeria 2018 Lassa fever outbreak. Science 363, 74\u201377. https:\/\/doi.org\/10.1126\/science.aau9343 (2019).","journal-title":"Science"},{"key":"72539_CR25","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4269\/ajtmh.1970.19.680","volume":"19","author":"SM Buckley","year":"1970","unstructured":"Buckley, S. M. & Casals, J. Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am. J. Trop. Med. Hyg. 19, 680\u2013691 (1970).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"72539_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3201\/eid2204.150155","volume":"22","author":"A Olayemi","year":"2016","unstructured":"Olayemi, A. et al. Arenavirus diversity and phylogeography of Mastomys natalensis rodents, Nigeria. Emerg. Infect. Dis. 22, 694\u2013697. https:\/\/doi.org\/10.3201\/eid2204.150155 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"72539_CR27","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1128\/jcm.01891-10","volume":"49","author":"DU Ehichioya","year":"2011","unstructured":"Ehichioya, D. U. et al. Current molecular epidemiology of Lassa virus in Nigeria. J. Clin. Microbiol. 49, 1157\u20131161. https:\/\/doi.org\/10.1128\/jcm.01891-10 (2011).","journal-title":"J. Clin. Microbiol."},{"key":"72539_CR28","doi-asserted-by":"publisher","first-page":"e0006971","DOI":"10.1371\/journal.pntd.0006971","volume":"12","author":"OK Oloniniyi","year":"2018","unstructured":"Oloniniyi, O. K. et al. Genetic characterization of Lassa virus strains isolated from 2012 to 2016 in southeastern Nigeria. PLoS Negl. Trop. Dis. 12, e0006971. https:\/\/doi.org\/10.1371\/journal.pntd.0006971 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"72539_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(19)30486-4","author":"MR Wiley","year":"2019","unstructured":"Wiley, M. R. et al. Lassa virus circulating in Liberia: A retrospective genomic characterisation. Lancet. Infect. Dis https:\/\/doi.org\/10.1016\/s1473-3099(19)30486-4 (2019).","journal-title":"Lancet. Infect. Dis"},{"key":"72539_CR30","doi-asserted-by":"publisher","first-page":"e2582","DOI":"10.1371\/journal.pntd.0002582","volume":"7","author":"D Safronetz","year":"2013","unstructured":"Safronetz, D. et al. Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali. PLoS Negl. Trop. Dis. 7, e2582. https:\/\/doi.org\/10.1371\/journal.pntd.0002582 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"72539_CR31","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.3389\/fmicb.2015.01037","volume":"6","author":"JT Manning","year":"2015","unstructured":"Manning, J. T., Forrester, N. & Paessler, S. Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage. Front. Microbiol. 6, 1037. https:\/\/doi.org\/10.3389\/fmicb.2015.01037 (2015).","journal-title":"Front. Microbiol."},{"key":"72539_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3201\/eid2403.171905","volume":"24","author":"SLM Whitmer","year":"2018","unstructured":"Whitmer, S. L. M. et al. New lineage of Lassa virus, Togo, 2016. Emerg. Infect. Dis. 24, 599\u2013602. https:\/\/doi.org\/10.3201\/eid2403.171905 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"72539_CR33","doi-asserted-by":"publisher","first-page":"e001119","DOI":"10.1136\/bmjgh-2018-001119","volume":"4","author":"DM Emperador","year":"2019","unstructured":"Emperador, D. M., Yimer, S. A., Mazzola, L. T., Norheim, G. & Kelly-Cirino, C. Diagnostic applications for Lassa fever in limited-resource settings. BMJ Glob. Health 4, e001119. https:\/\/doi.org\/10.1136\/bmjgh-2018-001119 (2019).","journal-title":"BMJ Glob. Health"},{"key":"72539_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jcv.2007.11.019","volume":"42","author":"P Emmerich","year":"2008","unstructured":"Emmerich, P., Gunther, S. & Schmitz, H. Strain-specific antibody response to Lassa virus in the local population of west Africa. J. Clin. Virol. 42, 40\u201344. https:\/\/doi.org\/10.1016\/j.jcv.2007.11.019 (2008).","journal-title":"J. Clin. Virol."},{"key":"72539_CR35","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1128\/jvi.02063-06","volume":"81","author":"J Botten","year":"2007","unstructured":"Botten, J. et al. HLA-A2-restricted protection against lethal lymphocytic choriomeningitis. J. Virol. 81, 2307\u20132317. https:\/\/doi.org\/10.1128\/jvi.02063-06 (2007).","journal-title":"J. Virol."},{"key":"72539_CR36","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.16989.1","author":"IS Lukashevich","year":"2019","unstructured":"Lukashevich, I. S., Paessler, S. & de la Torre, J. C. Lassa virus diversity and feasibility for universal prophylactic vaccine. F1000Research https:\/\/doi.org\/10.12688\/f1000research.16989.1 (2019).","journal-title":"F1000Research"},{"key":"72539_CR37","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.2147\/dddt.S147276","volume":"12","author":"BM Warner","year":"2018","unstructured":"Warner, B. M., Safronetz, D. & Stein, D. R. Current research for a vaccine against Lassa hemorrhagic fever virus. Drug Des. Dev. Ther. 12, 2519\u20132527. https:\/\/doi.org\/10.2147\/dddt.S147276 (2018).","journal-title":"Drug Des. Dev. Ther."},{"key":"72539_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.coviro.2019.07.006","volume":"37","author":"K Salami","year":"2019","unstructured":"Salami, K., Gouglas, D., Schmaljohn, C., Saville, M. & Tornieporth, N. A review of Lassa fever vaccine candidates. Curr. Opin. Virol. 37, 105\u2013111. https:\/\/doi.org\/10.1016\/j.coviro.2019.07.006 (2019).","journal-title":"Curr. Opin. Virol."},{"key":"72539_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1743-422x-5-74","volume":"5","author":"LM Branco","year":"2008","unstructured":"Branco, L. M. et al. Bacterial-based systems for expression and purification of recombinant Lassa virus proteins of immunological relevance. Virol. J. 5, 74. https:\/\/doi.org\/10.1186\/1743-422x-5-74 (2008).","journal-title":"Virol. J."},{"key":"72539_CR40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/1743-422x-8-314","volume":"8","author":"JN Grove","year":"2011","unstructured":"Grove, J. N. et al. Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol. J. 8, 314. https:\/\/doi.org\/10.1186\/1743-422x-8-314 (2011).","journal-title":"Virol. J."},{"key":"72539_CR41","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/1743-422x-8-478","volume":"8","author":"LM Branco","year":"2011","unstructured":"Branco, L. M. et al. Emerging trends in Lassa fever: Redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Virol. J. 8, 478. https:\/\/doi.org\/10.1186\/1743-422x-8-478 (2011).","journal-title":"Virol. J."},{"key":"72539_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw261","author":"ML Boisen","year":"2016","unstructured":"Boisen, M. L. et al. Field validation of the ReEBOV antigen rapid test for point-of-care diagnosis of ebola virus infection. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiw261 (2016).","journal-title":"J. Infect. Dis."},{"key":"72539_CR43","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/1743-422x-8-404","volume":"8","author":"LM Branco","year":"2011","unstructured":"Branco, L. M. et al. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Virol. J. 8, 404. https:\/\/doi.org\/10.1186\/1743-422x-8-404 (2011).","journal-title":"Virol. J."},{"key":"72539_CR44","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3201\/eid1607.100146","volume":"16","author":"D Safronetz","year":"2010","unstructured":"Safronetz, D. et al. Detection of Lassa virus Mali. Emerg. Infect. Dis. 16, 1123\u20131126. https:\/\/doi.org\/10.3201\/eid1607.100146 (2010).","journal-title":"Emerg. Infect. Dis."},{"key":"72539_CR45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2991\/jegh.k.190421.001","volume":"9","author":"BN Ogunro","year":"2019","unstructured":"Ogunro, B. N. et al. Detection of antibody and antigen for Lassa virus nucleoprotein in monkeys from southern Nigeria. J. Epidemiol. Glob. Health 9, 125\u2013127. https:\/\/doi.org\/10.2991\/jegh.k.190421.001 (2019).","journal-title":"J. Epidemiol. Glob. Health"},{"key":"72539_CR46","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/jci131958","volume":"130","author":"RW Cross","year":"2020","unstructured":"Cross, R. W. et al. Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death. J. Clin. Invest. 130, 539\u2013551. https:\/\/doi.org\/10.1172\/jci131958 (2020).","journal-title":"J. Clin. Invest."},{"key":"72539_CR47","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1080\/21645515.2017.1356500","volume":"13","author":"KA Cashman","year":"2017","unstructured":"Cashman, K. A. et al. A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever. Hum. Vacc. Immunother. 13, 2902\u20132911. https:\/\/doi.org\/10.1080\/21645515.2017.1356500 (2017).","journal-title":"Hum. Vacc. Immunother."},{"key":"72539_CR48","doi-asserted-by":"publisher","first-page":"11544","DOI":"10.1038\/ncomms11544","volume":"7","author":"JE Robinson","year":"2016","unstructured":"Robinson, J. E. et al. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits. Nat. Commun. 7, 11544. https:\/\/doi.org\/10.1038\/ncomms11544 (2016).","journal-title":"Nat. Commun."},{"key":"72539_CR49","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1126\/science.aam7260","volume":"356","author":"KM Hastie","year":"2017","unstructured":"Hastie, K. M. et al. Structural basis for antibody-mediated neutralization of Lassa virus. Science 356, 923\u2013928. https:\/\/doi.org\/10.1126\/science.aam7260 (2017).","journal-title":"Science"},{"key":"72539_CR50","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.cell.2019.07.020","volume":"178","author":"KM Hastie","year":"2019","unstructured":"Hastie, K. M. et al. Convergent structures illuminate features for germline antibody binding and pan-Lassa virus neutralization. Cell 178, 1004-1015.e1014. https:\/\/doi.org\/10.1016\/j.cell.2019.07.020 (2019).","journal-title":"Cell"},{"key":"72539_CR51","doi-asserted-by":"publisher","first-page":"8724","DOI":"10.1038\/s41598-020-65736-0","volume":"10","author":"ML Boisen","year":"2020","unstructured":"Boisen, M. L. et al. Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak. Sci. Rep. 10, 8724. https:\/\/doi.org\/10.1038\/s41598-020-65736-0 (2020).","journal-title":"Sci. Rep."},{"issue":"Pt 7","key":"72539_CR52","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1099\/0022-1317-69-7-1735","volume":"69","author":"RM Lewis","year":"1988","unstructured":"Lewis, R. M., Cosgriff, T. M., Griffin, B. Y., Rhoderick, J. & Jahrling, P. B. Immune serum increases arenavirus replication in monocytes. J. Gen. Virol. 69(Pt 7), 1735\u20131739 (1988).","journal-title":"J. Gen. Virol."},{"key":"72539_CR53","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0140-6736(87)90767-7","volume":"2","author":"JC Clegg","year":"1987","unstructured":"Clegg, J. C. & Lloyd, G. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Lancet 2, 186\u2013188 (1987).","journal-title":"Lancet"},{"key":"72539_CR54","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00153-20","author":"S Sakabe","year":"2020","unstructured":"Sakabe, S. et al. Identification of common CD8+ T cell epitopes from Lassa fever survivors in Nigeria and Sierra Leone. J. Virol. https:\/\/doi.org\/10.1128\/jvi.00153-20 (2020).","journal-title":"J. Virol."},{"key":"72539_CR55","doi-asserted-by":"publisher","first-page":"e1008352","DOI":"10.1371\/journal.ppat.1008352","volume":"16","author":"BM Sullivan","year":"2020","unstructured":"Sullivan, B. M. et al. High crossreactivity of human T cell responses between Lassa virus lineages. PLoS Pathog. 16, e1008352. https:\/\/doi.org\/10.1371\/journal.ppat.1008352 (2020).","journal-title":"PLoS Pathog."},{"key":"72539_CR56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri.2016.138","volume":"17","author":"JB Prescott","year":"2017","unstructured":"Prescott, J. B. et al. Immunobiology of Ebola and Lassa virus infections. Nat. Rev. Immunol. 17, 195\u2013207. https:\/\/doi.org\/10.1038\/nri.2016.138 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"72539_CR57","first-page":"75","volume":"262","author":"JB McCormick","year":"2002","unstructured":"McCormick, J. B. & Fisher-Hoch, S. P. Lassa fever. Curr. Top. Microbiol. Immunol. 262, 75\u2013109 (2002).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"72539_CR58","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/infdis\/149.3.420","volume":"149","author":"PB Jahrling","year":"1984","unstructured":"Jahrling, P. B., Peters, C. J. & Stephen, E. L. Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. J. Infect. Dis. 149, 420\u2013427 (1984).","journal-title":"J. Infect. Dis."},{"key":"72539_CR59","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1128\/IAI.44.2.528-533.1984","volume":"44","author":"PB Jahrling","year":"1984","unstructured":"Jahrling, P. B. & Peters, C. J. Passive antibody therapy of Lassa fever in cynomolgus monkeys: Importance of neutralizing antibody and Lassa virus strain. Infect. Immun. 44, 528\u2013533 (1984).","journal-title":"Infect. Immun."},{"key":"72539_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.coviro.2019.07.003","volume":"37","author":"RW Cross","year":"2019","unstructured":"Cross, R. W. et al. Antibody therapy for Lassa fever. Curr. Opin. Virol. 37, 97\u2013104. https:\/\/doi.org\/10.1016\/j.coviro.2019.07.003 (2019).","journal-title":"Curr. Opin. Virol."},{"key":"72539_CR61","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nm.4396","volume":"23","author":"CE Mire","year":"2017","unstructured":"Mire, C. E. et al. Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever. Nat. Med. 23, 1146\u20131149. https:\/\/doi.org\/10.1038\/nm.4396 (2017).","journal-title":"Nat. Med."},{"key":"72539_CR62","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.antiviral.2016.08.012","volume":"133","author":"RW Cross","year":"2016","unstructured":"Cross, R. W. et al. Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies. Antiviral Res. 133, 218\u2013222. https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.012 (2016).","journal-title":"Antiviral Res."},{"key":"72539_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2018.05.002","author":"KM Hastie","year":"2018","unstructured":"Hastie, K. M. & Saphire, E. O. Lassa virus glycoprotein: Stopping a moving target. Curr. Opin. Virol. https:\/\/doi.org\/10.1016\/j.coviro.2018.05.002 (2018).","journal-title":"Curr. Opin. Virol."},{"key":"72539_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.1890370102","volume":"37","author":"JB McCormick","year":"1992","unstructured":"McCormick, J. B., Mitchell, S. W., Kiley, M. P., Ruo, S. & Fisher-Hoch, S. P. Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys. J. Med. Virol. 37, 1\u20137 (1992).","journal-title":"J. Med. Virol."},{"key":"72539_CR65","doi-asserted-by":"publisher","first-page":"e0003736","DOI":"10.1371\/journal.pntd.0003736","volume":"9","author":"D Safronetz","year":"2015","unstructured":"Safronetz, D. et al. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. PLoS Negl. Trop. Dis. 9, e0003736. https:\/\/doi.org\/10.1371\/journal.pntd.0003736 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"72539_CR66","unstructured":"Zalgen Labs. ReLASV\u00ae Pan-Lassa NP IgG\/IgM ELISA Kit. https:\/\/www.zalgen.com\/wp-content\/uploads\/2019\/05\/PI-10004.pdf."},{"key":"72539_CR67","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nature01470","volume":"422","author":"X Wei","year":"2003","unstructured":"Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422, 307\u2013312. https:\/\/doi.org\/10.1038\/nature01470 (2003).","journal-title":"Nature"},{"key":"72539_CR68","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1128\/IAI.37.2.771-778.1982","volume":"37","author":"PB Jahrling","year":"1982","unstructured":"Jahrling, P. B., Smith, S., Hesse, R. A. & Rhoderick, J. B. Pathogenesis of Lassa virus infection in guinea pigs. Infect. Immun. 37, 771\u2013778 (1982).","journal-title":"Infect. Immun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72539-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72539-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72539-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T19:52:12Z","timestamp":1670356332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72539-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72539"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72539-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"12 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Tulane University and its various academic and industry partners have filed US and foreign patent applications for countermeasures to emerging viruses. Technical information may also be kept as trade secrets. If commercial products are developed, including Lassa diagnostics, MLH, MLB, DSKN, DJB, RWC, APK, KMH, MMR, IA, SK, RL, JGS, JSS, TWG, EOS, CTH, DSG, RFG and LMB may receive royalties or profits. This does not alter our adherence to all policies of the NIH and <i>Scientific Reports<\/i> on sharing data and materials. The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16030"}}